Shellback Capital’s SkinHealth Systems SKIN Stock Holding History

Shellback Capital’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200,000	Closed	-$2.53M	–	105
2023 Q1	$2.53M	Buy	+200,000	New	+$2.31M	0.28%	76

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Shellback Capital's SKIN Position: Q2 2023 in Review

Shellback Capital sold out of SkinHealth Systems (SKIN) in Q2 2023, closing a stake of 200,000 shares — an estimated $2.53M sold.

Shellback Capital first reported a position in SKIN in Q1 2023 and held it in 1 quarter. The position peaked at $2.53M in Q1 2023. 135 funds tracked by Wall St. Rank hold SKIN as of Q2 2023.

Shellback Capital reported no remaining SkinHealth Systems position as of Q2 2023 after selling out during the quarter.
Shellback Capital sold 200,000 SkinHealth Systems shares in Q2 2023, an estimated $2.53M.
Shellback Capital first reported a position in SkinHealth Systems in Q1 2023 and held it in 1 quarter.
Shellback Capital's SkinHealth Systems position peaked at $2.53M in Q1 2023.
135 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2023.

Based on Shellback Capital's 13F filing for Q2 2023, filed 14 Aug 2023.